WO1994023049A3 - The introduction and expression of large genomic sequences in transgenic animals - Google Patents
The introduction and expression of large genomic sequences in transgenic animals Download PDFInfo
- Publication number
- WO1994023049A3 WO1994023049A3 PCT/US1994/003619 US9403619W WO9423049A3 WO 1994023049 A3 WO1994023049 A3 WO 1994023049A3 US 9403619 W US9403619 W US 9403619W WO 9423049 A3 WO9423049 A3 WO 9423049A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- app
- gene
- yac
- expression
- transgenic mice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Humanized animals, e.g. knockin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4239093A | 1993-04-02 | 1993-04-02 | |
US08/042,390 | 1993-04-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1994023049A2 WO1994023049A2 (en) | 1994-10-13 |
WO1994023049A9 WO1994023049A9 (en) | 1994-11-24 |
WO1994023049A3 true WO1994023049A3 (en) | 1995-01-05 |
Family
ID=21921669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/003619 WO1994023049A2 (en) | 1993-04-02 | 1994-04-01 | The introduction and expression of large genomic sequences in transgenic animals |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1994023049A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877175B2 (en) | 2006-09-14 | 2014-11-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
US9127084B2 (en) | 2006-09-14 | 2015-09-08 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9119338D0 (en) * | 1991-09-10 | 1991-10-23 | Inst Of Animal Physiology And | Control of gene expression |
JPH07506720A (en) * | 1992-01-07 | 1995-07-27 | アテナ ニューロサイエンシーズ, インコーポレイテッド | Transgenic animal model of Alzheimer's disease |
US6610493B1 (en) | 1993-06-17 | 2003-08-26 | Brigham And Women's Hospital | Screening compounds for the ability to alter the production of amyloid-β peptide |
US6264915B1 (en) | 1992-09-13 | 2001-07-24 | The President And Fellows Of Harvard College | Process for detecting potential carcinogens |
JPH09507746A (en) * | 1993-10-27 | 1997-08-12 | アテナ ニューロサイエンシズ,インコーポレイティド | Transgenic animal containing APP allele with Swedish mutation |
US6025183A (en) * | 1994-02-28 | 2000-02-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Transgenic animal assay system for anti-cholinesterase substances |
WO1995034640A1 (en) * | 1994-06-13 | 1995-12-21 | Henry Ford Health System | A novel neuronal-neonatal gene: neuronatin |
US6531586B1 (en) | 1995-04-28 | 2003-03-11 | The Hospital For Sick Children | Genetic sequences related to Alzheimer's Disease |
US5986054A (en) | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
US6210919B1 (en) | 1995-04-28 | 2001-04-03 | Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
US5777093A (en) * | 1995-05-16 | 1998-07-07 | Ramot-University Authority For Applied Research & Industrial Development Ltd. | cDNAs associated with ataxia-telangiectasia |
US5858661A (en) * | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
US5728807A (en) * | 1995-05-16 | 1998-03-17 | Ramot-University Authority For Applied Research And Industrial Development, Ltd. | Mutated proteins associated with ataxia-telangiectasia |
JPH11507821A (en) * | 1995-06-07 | 1999-07-13 | アセナ ニューロサイエンシーズ,インコーポレイテッド | Methods for identifying therapeutic agents for Alzheimer's disease using transgenic animal models |
CA2221986A1 (en) * | 1995-06-07 | 1996-12-19 | Athena Neurosciences, Inc. | Method for identifying alzheimer's disease therapeutics using transgenic animal models |
US6717031B2 (en) | 1995-06-07 | 2004-04-06 | Kate Dora Games | Method for selecting a transgenic mouse model of alzheimer's disease |
WO1997027296A1 (en) * | 1996-01-26 | 1997-07-31 | Hsc Research And Development Limited Partnership | Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
US6140309A (en) * | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
US6077697A (en) * | 1996-04-10 | 2000-06-20 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6025155A (en) * | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
JP2000513230A (en) | 1996-07-01 | 2000-10-10 | エイ. ライト,ジム | Oligonucleotides from the untranslated region of a housekeeping gene and methods of using the same to regulate cell growth |
WO1999009150A1 (en) * | 1996-08-15 | 1999-02-25 | Bayer Corporation | Method of introducing modifications into a gene |
US5898094A (en) * | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
EP1707051B1 (en) * | 1997-02-28 | 2010-01-13 | Kyowa Hakko Kirin Co., Ltd. | Human chromosome fragment, and vector containing it |
US7973156B2 (en) | 1997-08-21 | 2011-07-05 | Quark Pharmaceuticals Inc. | Hypoxia-regulated genes |
JP4354633B2 (en) | 1997-08-21 | 2009-10-28 | クアーク ファーマシューティカルズ、インコーポレイテッド | Hypoxia-regulated gene |
CA2318479C (en) | 1998-01-12 | 2009-03-24 | Georgetown University Medical Center | G protein-related kinase mutants in essential hypertension |
US6787318B1 (en) | 1999-06-01 | 2004-09-07 | Roskamp Research Institute, Llc | Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology |
US6875582B1 (en) | 1999-08-19 | 2005-04-05 | Omniscience Pharmaceuticals, Inc. | Methods and targets of antibiotic resistance |
EP1252292A4 (en) | 2000-01-24 | 2004-11-17 | Univ Ramot | Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby |
HUP0300810A2 (en) | 2000-07-20 | 2003-08-28 | M.G.V.S. Ltd. | Artifical vascular grafts, and methods of producing and using same |
US20040037828A1 (en) | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
EP2138583A1 (en) | 2000-12-22 | 2009-12-30 | Institut National De La Recherche Agronomique | Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
CA2441937A1 (en) * | 2001-05-30 | 2002-12-05 | Chromos Molecular Systems, Inc. | Chromosome-based platforms |
US8178128B2 (en) | 2001-12-05 | 2012-05-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Nanoparticles containing polymeric nucleic acid homologs |
US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
ES2245591B1 (en) | 2004-04-06 | 2007-04-01 | Consejo Sup. Investigaciones Cientificas | NEW PROCEDURE FOR GENERATING NON-HUMAN TRANSGENIC ANIMALS, AND THE TRANSGENIC ANIMALS SO OBTAINED. |
ES2679282T3 (en) | 2004-10-22 | 2018-08-23 | Revivicor Inc. | Transgenic pigs that lack endogenous immunoglobulin light chain |
ES2316209B1 (en) * | 2005-12-02 | 2009-11-13 | Universidad Autonoma De Madrid | ANZAL MODEL OF ALZHEIMER'S DISEASE, PROCEDURE OF OBTAINING AND ITS APPLICATIONS. |
WO2007088418A1 (en) | 2006-01-31 | 2007-08-09 | Multi Gene Vascular Systems, Inc. | Drug-eluting intravascular prostheses and methods of use |
AU2007294858B2 (en) | 2006-09-14 | 2011-05-12 | Medgenics Medical Israel, Ltd | Long lasting drug formulations |
WO2008068024A2 (en) * | 2006-12-06 | 2008-06-12 | Universität Zürich | Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
WO2008152507A2 (en) | 2007-03-16 | 2008-12-18 | Multigene Vascular Systems, Inc. | Compositions and methods for treating ophthalmic disorders |
CA2682093A1 (en) | 2007-03-29 | 2008-10-09 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
DK2348827T3 (en) | 2008-10-27 | 2015-07-20 | Revivicor Inc | IMMUNICIPLY COMPROMATED PETS |
EP3060144A1 (en) | 2013-10-24 | 2016-08-31 | Medgenics Medical Israel, Ltd | Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0518583A1 (en) * | 1991-06-13 | 1992-12-16 | Zeneca Limited | Nucleotide sequences |
WO1993005165A1 (en) * | 1991-09-10 | 1993-03-18 | Agriculture And Food Research Council | Yeast artificial chromosomes and their use in the control of gene expression |
WO1994000569A1 (en) * | 1992-06-18 | 1994-01-06 | Genpharm International, Inc. | Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
-
1994
- 1994-04-01 WO PCT/US1994/003619 patent/WO1994023049A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0518583A1 (en) * | 1991-06-13 | 1992-12-16 | Zeneca Limited | Nucleotide sequences |
WO1993005165A1 (en) * | 1991-09-10 | 1993-03-18 | Agriculture And Food Research Council | Yeast artificial chromosomes and their use in the control of gene expression |
WO1994000569A1 (en) * | 1992-06-18 | 1994-01-06 | Genpharm International, Inc. | Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
Non-Patent Citations (5)
Title |
---|
B.E. PEARSON AND T.K. CHOI: "Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice", PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 10578 - 10582 * |
B.T. LAMB AND J.H. GEARHART: "Characterization and manipulation of yeast artificial chromosomes containing the human amyloid precursor protein gene", J. CELL. BIOCHEM. SUPPL. 0 (16 PART E), 1992, pages 212 * |
B.T. LAMB ET AL.;: "Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice", NATURE GENETICS, vol. 5, 1993, pages 22 - 30 * |
Keystone Symposium on advances in under- standing neurodegenerative disorders, Big Sky, Montana, USA, March 28 - April 4, 1992. * |
W.M. STRAUSS ET AL.;: "Germ line transmission of a yeast artificial chromosome spanning the murine alpha-1(I) collagen locus", SCIENCE, vol. 259, 1993, pages 1904 - 1907 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877175B2 (en) | 2006-09-14 | 2014-11-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
US9127084B2 (en) | 2006-09-14 | 2015-09-08 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
Also Published As
Publication number | Publication date |
---|---|
WO1994023049A2 (en) | 1994-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994023049A3 (en) | The introduction and expression of large genomic sequences in transgenic animals | |
EP1826215B1 (en) | Method of obtaining the expression or improving the rate of expression of a gene | |
Langston et al. | Retinoic acid-responsive enhancers located 3 of the Hox A and Hox B homeobox gene clusters: functional analysis | |
Kollias et al. | Regulated expression of human Aγ-, β-, and hybrid γβ-globin genes in transgenic mice: manipulation of the developmental expression patterns | |
Harel et al. | Efficient genome engineering approaches for the short-lived African turquoise killifish | |
Klüppel et al. | The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. | |
Krimpenfort et al. | Transcription of T cell receptor beta‐chain genes is controlled by a downstream regulatory element. | |
Ainscough et al. | Imprinting of Igf2 and H19 from a 130 kb YAC transgene | |
Ariel et al. | Methylation patterns of testis-specific genes. | |
Drewell et al. | Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch | |
Kollias et al. | Regulated expression of human A?-,?-, and hybrid??-globin genes in transgenic mice: Manipulation of the developmental expression patterns | |
CN112334157A (en) | Compositions and methods for treating spinal muscular atrophy | |
Brorson et al. | Analysis of a new class I gene mapping to the Hmt region of the mouse | |
Koga et al. | Germline transgenesis of zebrafish using the medaka Tol1 transposon system | |
Dinkel et al. | Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells | |
Matsuura et al. | Xist expression from an Xist YAC transgene carried on the mouse Y chromosome | |
Tripathi et al. | Definition of a T-cell receptor β gene core enhancer of V (D) J recombination by transgenic mapping | |
Gerlinger et al. | B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavychain enhancer | |
KR20100102235A (en) | A method to reduce directional bias in transcription | |
HUP0101961A2 (en) | Modifying the expression of the fsh beta gene by homologous recombination | |
CA2451608C (en) | Process for constructing a mutant utilizing the igh 3' enhancer | |
CN113088537B (en) | Construction method and application of TLR9 gene humanized animal model | |
Cemal et al. | Insertion of expanded CAG trinucleotide repeat motifs into a yeast artificial chromosome containing the human Machado–Joseph disease gene | |
Chong et al. | A Functional chromatin domain does not resist X chromosome inactivation: silencing of cLys correlates with methylation of a dual promoter-replication origin | |
Liebscher et al. | Cloning of carp preproinsulin cDNA in the bacterial plasmid pBR322 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/14-14/14,DRAWINGS,REPLACED BY NEW PAGES 1/21-21/21;DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |